US38141G1040 - Common Stock

Taking everything into account, **GS** scores **3** out of 10 in our fundamental rating. **GS** was compared to 207 industry peers in the **Capital Markets** industry. **GS** has a bad profitability rating. Also its financial health evaluation is rather negative. **GS** is not valued too expensively and it also shows a decent growth rate.

Each year in the past 5 years **GS** has been profitable.

The **Return On Invested Capital** of **GS** (**0.67%**) is worse than **81.86%** of its industry peers.

The **Average Return On Invested Capital** over the past 3 years for **GS** is significantly below the industry average of **9.53%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.46% | ||

ROE | 6.16% | ||

ROIC | 0.67% |

ROA(3y)0.99%

ROA(5y)0.96%

ROE(3y)12.57%

ROE(5y)11.48%

ROIC(3y)1.42%

ROIC(5y)1.37%

The **Operating Margin** of **GS** (**10.20%**) is worse than **76.96%** of its industry peers.

In the last couple of years the **Operating Margin** of **GS** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 10.2% | ||

PM (TTM) | 7.16% | ||

GM | 39.5% |

OM growth 3Y0.61%

OM growth 5Y-5.17%

PM growth 3Y2.89%

PM growth 5Y13.08%

GM growth 3Y-0.66%

GM growth 5Y-2.64%

The number of shares outstanding for **GS** has been increased compared to 1 year ago.

The number of shares outstanding for **GS** has been reduced compared to 5 years ago.

The debt/assets ratio for **GS** has been reduced compared to a year ago.

Based on the Altman-Z score of **-0.24**, we must say that **GS** is in the distress zone and has some risk of bankruptcy.

With a **Altman-Z score** value of **-0.24**, **GS** is not doing good in the industry: **88.24%** of the companies in the same industry are doing better.

The **Debt to Equity ratio** of **GS** (**7.98**) is worse than **87.75%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 7.98 | ||

Debt/FCF | N/A | ||

Altman-Z | -0.24 |

ROIC/WACCN/A

WACCN/A

The **Current ratio** of **GS** (**0.37**) is worse than **80.88%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.37 | ||

Quick Ratio | 0.37 |

The earnings per share for **GS** have decreased strongly by **-42.10%** in the last year.

The **Earnings Per Share** has been growing by **8.71%** on average over the past years. This is quite good.

The **Revenue** has grown by **63.68%** in the past year. This is a very strong growth!

Measured over the past years, **GS** shows a quite strong growth in **Revenue**. The Revenue has been growing by **9.58%** on average per year.

EPS 1Y (TTM)-42.1%

EPS 3Y12.7%

EPS 5Y8.71%

EPS growth Q2Q-33.7%

Revenue 1Y (TTM)63.68%

Revenue growth 3Y7.76%

Revenue growth 5Y9.58%

Revenue growth Q2Q54.35%

The **Revenue** is expected to grow by **0.88%** on average over the next years.

EPS Next Y-17.93%

EPS Next 2Y9.1%

EPS Next 3Y10.32%

EPS Next 5Y4.23%

Revenue Next Year-4.32%

Revenue Next 2Y2.84%

Revenue Next 3Y3.04%

Revenue Next 5Y0.88%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

With a **Price/Earnings** ratio of **15.84**, **GS** is valued correctly.

Compared to an average S&P500 **Price/Earnings** ratio of **24.81**, **GS** is valued a bit cheaper.

Based on the **Price/Forward Earnings** ratio, **GS** is valued a bit cheaper than the industry average as 64.22% of the companies are valued more expensively.

The average S&P500 **Price/Forward Earnings** ratio is at **19.91**. **GS** is valued rather cheaply when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 15.84 | ||

Fwd PE | 9.63 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 10.45 |

PEG (NY)N/A

PEG (5Y)1.82

EPS Next 2Y9.1%

EPS Next 3Y10.32%

With a **Yearly Dividend Yield** of **3.22%**, **GS** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **8.08**, **GS** has a dividend in line with its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.59**, **GS** pays a bit more dividend than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.22% |

The dividend of **GS** is nicely growing with an annual growth rate of **19.03%**!

Dividend Growth(5Y)19.03%

Div Incr Years12

Div Non Decr Years13

DP57.26%

EPS Next 2Y9.1%

EPS Next 3Y10.32%

**GOLDMAN SACHS GROUP INC**

NYSE:GS (12/6/2023, 11:38:08 AM)

**344.39**

**+2.64 (+0.77%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap112.31B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.22% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 15.84 | ||

Fwd PE | 9.63 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)1.82

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.46% | ||

ROE | 6.16% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 10.2% | ||

PM (TTM) | 7.16% | ||

GM | 39.5% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.06

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 7.98 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.37 | ||

Quick Ratio | 0.37 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-42.1%

EPS 3Y12.7%

EPS 5Y

EPS growth Q2Q

EPS Next Y-17.93%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)63.68%

Revenue growth 3Y7.76%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y